Get the Stockscreener App
17.50
0.79%
-0.14
Pre-market:
17.39
-0.11
-0.63%
Overview
News
Price History
Option Chain
Financials
Why KVUE Down?
Discussions
Forecast
Dividend History
Kenvue Inc stock is traded at $17.50, with a volume of 78.71M.
It is down -0.79% in the last 24 hours and up +1.80% over the past month.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced November 2025 that it signed a deal to be fully acquired by Kimberly-Clark with the deal expected to close during the second half of 2026.
See More
Previous Close:
$17.64
Open:
$17.7
24h Volume:
78.71M
Relative Volume:
1.85
Market Cap:
$33.53B
Revenue:
$15.01B
Net Income/Loss:
$1.43B
P/E Ratio:
23.52
EPS:
0.744
Net Cash Flow:
$1.63B
1W Performance:
-0.51%
1M Performance:
+1.80%
6M Performance:
-23.38%
1Y Performance:
-18.38%
1-Day Range:
$17.43
$17.87
1-Week Range:
$17.27
$17.89
52-Week Range:
$14.02
$25.17
Kenvue Inc Stock (KVUE) Company Profile
Name
Kenvue Inc
Sector
Industry
Phone
908-874-1200
Address
1 KENVUE WAY, SUMMIT
Compare KVUE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KVUE
Kenvue Inc
|
17.50 | 33.80B | 15.01B | 1.43B | 1.63B | 0.744 |
|
PG
Procter Gamble Co
|
148.34 | 347.41B | 85.26B | 16.53B | 14.85B | 6.7488 |
|
UL
Unilever Plc Adr
|
67.56 | 146.78B | 64.99B | 6.71B | 6.53B | 2.74 |
|
CL
Colgate Palmolive Co
|
85.76 | 68.68B | 20.10B | 3.04B | 3.44B | 3.569 |
|
EL
Estee Lauder Cos Inc
|
116.44 | 41.94B | 14.42B | -930.00M | 1.05B | -2.5832 |
Kenvue Inc Stock (KVUE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-29-25 | Downgrade | Canaccord Genuity | Buy → Hold |
| Sep-26-25 | Upgrade | Rothschild & Co Redburn | Neutral → Buy |
| Apr-10-25 | Initiated | Redburn Atlantic | Neutral |
| Mar-24-25 | Initiated | Evercore ISI | In-line |
| Jan-06-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-12-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Sep-24-24 | Initiated | Jefferies | Buy |
| Sep-24-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| May-28-24 | Resumed | Citigroup | Neutral |
| Apr-11-24 | Initiated | Bernstein | Underperform |
| Apr-03-24 | Initiated | William Blair | Mkt Perform |
| Mar-01-24 | Resumed | Goldman | Neutral |
| Nov-17-23 | Initiated | Piper Sandler | Neutral |
| Sep-11-23 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-07-23 | Initiated | Canaccord Genuity | Buy |
| Sep-06-23 | Initiated | Argus | Hold |
| Aug-24-23 | Upgrade | Goldman | Neutral → Buy |
| Jul-25-23 | Initiated | Edward Jones | Buy |
| Jun-01-23 | Initiated | HSBC Securities | Hold |
| May-30-23 | Initiated | BofA Securities | Buy |
| May-30-23 | Initiated | Citigroup | Neutral |
| May-30-23 | Initiated | Deutsche Bank | Hold |
| May-30-23 | Initiated | Exane BNP Paribas | Neutral |
| May-30-23 | Initiated | Goldman | Neutral |
| May-30-23 | Initiated | JP Morgan | Overweight |
| May-30-23 | Initiated | RBC Capital Mkts | Outperform |
| May-30-23 | Initiated | UBS | Neutral |
View All
Kenvue Inc Stock (KVUE) Latest News
CIBC Asset Management Inc Sells 93,491 Shares of Kenvue Inc. $KVUE - MarketBeat
Kimberly-Clark Just Proved Itself As Its Purchase Of Kenvue Nears (Upgrade) (NASDAQ:KMB) - Seeking Alpha
Kimberly-Clark Posts Higher Profit Ahead of Kenvue Vote - The Wall Street Journal
Kenvue stock edges higher as Kimberly-Clark profit beat puts takeover vote back in play - TechStock²
KMB: Organic growth, higher adjusted profits, and Kenvue acquisition set stage for 2026 momentum - TradingView
Kenvue Inc. $KVUE Shares Sold by Envestnet Portfolio Solutions Inc. - MarketBeat
Jim Cramer says Kimberly-Clark’s merger with Kenvue could keep this stock in its place - MSN
How (KVUE) Movements Inform Risk Allocation Models - Stock Traders Daily
Jim Cramer Says Kimberly-Clark’s Merger With Kenvue “Could Keep This Stock in Its Place” - Insider Monkey
Kenvue Inc. $KVUE Shares Sold by Strs Ohio - MarketBeat
Commerzbank Aktiengesellschaft FI Raises Stake in Kenvue Inc. $KVUE - MarketBeat
Investment House LLC Reduces Position in Kenvue Inc. $KVUE - MarketBeat
Callahan Advisors LLC Takes Position in Kenvue Inc. $KVUE - MarketBeat
Can Kenvue Inc. stock outperform in a bear marketQuarterly Market Summary & AI Powered Buy/Sell Recommendations - mfd.ru
Kenvue Inc. $KVUE Shares Sold by Wealth Enhancement Advisory Services LLC - MarketBeat
Kenvue stock steadies near $18 as investors eye Jan. 29 merger vote — here’s what matters next week - TechStock²
Kenvue Inc. $KVUE Shares Sold by UniSuper Management Pty Ltd - MarketBeat
483,928 Shares in Kenvue Inc. $KVUE Purchased by Y Intercept Hong Kong Ltd - MarketBeat
Analysts Offer Insights on Consumer Goods Companies: Kenvue, Inc. (KVUE) and Primo Brands (PRMB) - The Globe and Mail
Kenvue Unit Asks Justices To Clarify Class Cert. Expert Rules - Law360
The New York Stock Exchange | NYSE - NYSE
Kenvue (KVUE) stock price barely budges as Kimberly-Clark deal vote nears - TechStock²
Kenvue stock rating reiterated at Sector Perform by RBC Capital - Investing.com Canada
RBC Capital Maintains Kenvue(KVUE.US) With Hold Rating, Maintains Target Price $21 - 富途资讯
Kenvue stock rating reiterated at Sector Perform by RBC Capital By Investing.com - Investing.com Australia
Assessing Kenvue (KVUE) After Its Separation From Johnson & Johnson - Yahoo Finance
ISS Backs Kimberly-Clark Kenvue Deal As Valuation Signals Undervaluation - Sahm
Kenvue stock price jumps 2% as KVUE takeover vote nears — what traders watch next - TechStock²
Kenvue stock price rebounds as merger vote nears — what KVUE traders watch next - TechStock²
Kenvue Introduces ORSL For Diarrheal And eRZL For Daily Hydration - SMEStreet
Allstate Corp Makes New Investment in Kenvue Inc. $KVUE - MarketBeat
Johnson & Johnson: Defensive Strength, Disciplined Growth, and Long-Term Value - Investing.com
Consumer health firm Kenvue announces dual brand strategy with two hydration solutions - ET HealthWorld
Kenvue stock price slips as Kimberly-Clark drops, deal vote stays in focus - TechStock²
ISS Backs Kenvue (KVUE) Deal, Investors Debate Tylenol and Litigation Risks - Finviz
Kenvue bets on dual‑brand push to dominate India’s fast‑growing hydration market - Moneycontrol
Kenvue differentiates its ORS brand from its electrolyte drink - BusinessLine
Kenvue stock steadies as Kimberly-Clark deal vote nears, with lawsuits in the mix - TechStock²
Vest Financial LLC Grows Stock Position in Kenvue Inc. $KVUE - MarketBeat
ISS backs Kenvue (KVUE) deal, investors debate Tylenol and litigation risks - MSN
ISS recommends shareholders approve Kimberly-Clark's planned Kenvue deal - MSN
The New Titan of Wellness: Kimberly-Clark’s $48.7 Billion Kenvue Acquisition Reshapes Consumer Staples - The Chronicle-Journal
Kenvue stock ticks up as investors size up Kimberly-Clark takeover vote in days - TechStock²
Activist investors do not plan to play nice this year as they eye more corporate breakups - marketscreener.com
Analysts Offer Insights on Consumer Goods Companies: Kenvue, Inc. (KVUE) and McCormick & Company (MKC) - The Globe and Mail
A Look Into Kenvue Inc's Price Over Earnings - Benzinga
Is Johnson & Johnson A Dividend Stock, Or Something Else? (NYSE:JNJ) - Seeking Alpha
Massachusetts Financial Services Co. MA Sells 3,862,828 Shares of Kenvue Inc. $KVUE - MarketBeat
Published on: 2026-01-19 01:22:15 - baoquankhu1.vn
Portfolio Recap: Can Kenvue Inc weather a recession2025 Investor Takeaways & Short-Term Swing Trade Alerts - baoquankhu1.vn
Kenvue stock has a new catalyst: ISS backs Kimberly-Clark merger ahead of Jan. 29 vote - TechStock²
Kenvue Inc Stock (KVUE) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.49%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):